Skip to main content
. Author manuscript; available in PMC: 2016 Aug 13.
Published in final edited form as: J Med Chem. 2015 Jul 20;58(15):5789–5807. doi: 10.1021/acs.jmedchem.5b00310

Table 1.

Inhibition of Tubulin Polymerization, Binding of Colchicine to Tubulin, and Growth of MCF-7 Human Breast Carcinoma Cells by Compounds 6–45 and References 15

graphic file with name nihms715998u2.jpg
compd R X tubulin assembly IC50 ± SDa (μM) MCF-7 IC50 ± SDb,c (nM) colchicine binding inhibitionc,d (% ± SD)
6 4-Br S 2.4 ± 0.1 400 ± 70 33 ± 2
7 4-Br C=O >20 (partial activity)e 430 ± 100 ndf
8 4-Cl S 1.6 ± 0.07 290 ± 50 48 ± 5
9 4-Cl C=O 3.6 ± 0.2 260 ± 50 38 ± 3
10 4-Cl CH2 17 ± 0.2 >5000 nd
11 4-F S 1.7 ± 0.07 80 ± 30 80 ± 0.4
12 4-F C=O 1.6 ± 0.08 65 ± 7 63 ± 1
13 4-MeO S >20 (partial activity)e 1400 ± 300 nd
14 4-MeO C=O >20 (no activity)g >5000 nd
15 5-Br S 1.3 ± 0.1 320 ± 100 39 ± 3
16 5-Br C=O >40 530 ± 100 nd
17 5-Br CH2 4.0 ± 0.5 700 ± 300 31 ± 2
18 5-Cl S 1.5 ± 0.2 280 ± 70 49 ± 5
19 5-Cl C=O >20 330 ± 100 nd
20 5-Cl CH2 4.4 ± 0.8 310 ± 10 38 ± 3
21 5-F S 1.5 ± 0.1 300 ± 0 61 ± 4
22 5-F C=O 13 ± 0.4 240 ± 90 nd
23 5-OMe S 2.1 ± 0.01 200 ± 80 58 ± 0.5
24 5-OMe C=O 8.3 ± 1 170 ± 60 nd
25 5-OMe CH2 3.5 ± 0.4 100 ± 0 41 ± 0.9
26 6-Br S 1.9 ± 0.2 9.0 ± 2 87 ± 0.6
27 6-Br C=O 1.3 ± 0.2 30 ± 2 86 ± 0.4
28 6-Cl S 1.2 ± 0.2 20 ± 10 88 ± 3
29 6-Cl C=O 1.4 ± 0.06 35 ± 7 71 ± 5
30 6-Cl CH2 1.6 ± 0.01 55 ± 20 72 ± 6
31 6-F S 2.4 ± 0.2 80 ± 20 74 ± 2
32 6-F C=O 10 ± 0.4 600 ± 0 nd
33 6-MeO S 1.1 ± 0.1 1.3 ± 0.6 96 ± 1
34 6-MeO C=O 1.2 ± 0.06 30 ± 10 95 ± 0.4
35 7-Br S 1.6 ± 0.2 25 ± 5 82 ± 1
36 7-Br C=O 1.7 ± 0.1 4.0 ± 0.5 72 ± 0.3
37 7-Cl S 1.3 ± 0.2 50 ± 10 82 ± 0.3
38 7-Cl C=O 1.8 ± 0.05 9.0 ± 1 69 ± 0.5
39 7-Cl CH2 2.4 ± 0.2 200 ± 0 50 ± 4
40 7-F S 1.0 ± 0.1 20 ± 9 92 ± 0.3
41 7-F C=O 1.7 ± 0.1 30 ± 0 67 ± 3
42 7-OMe S 1.2 ± 0.01 19 ± 10 87 ± 2
43 7-OMe C=O 1.8 ± 0.1 200 ± 0 62 ± 3
44 6,7-Cl2 S 1.2 ± 0.1 7.0 ± 3 92 ± 2
45 6,7-Cl2 C=O 1.5 ± 0.03 15 ± 5 93 ± 0.7
1 3.2 ± 0.4 5.0 ± 1 nd
2 1.0 ± 0.1 13 ± 3 98 ± 0.6
3h 3.3 ± 0.1 52 ± 7 nd
4i 2.0 ± 0.2 13 ± 3 93 ± 0.8
5i 2.5 ± 0.3 42 ± 10 76 ± 0.2
a

Inhibition of tubulin polymerization. Tubulin was at 10 μM in the assembly assay.

b

Inhibition of growth of MCF-7 human breast carcinoma cells.

c

Compounds that inhibited tubulin assembly with IC50 ≤ 5 μM were tested in the cellular and colchicine binding assays.

d

Inhibition of [3H]colchicine binding. Tubulin was at 1 μM. Both [3H]colchicine and inhibitor were at 5 μM.

e

Partial inhibition at 20 μM.

f

No data.

g

Little or no activity at 20 μM.

h

Reference 15.

i

Reference 16.